FDA Inspection
Sher Institute for Reproductive Medicine New Jersey P.A.Sher Institute for Reproductive Medicine New Jersey P.A. – FDA Inspection, Mar 14, 2011
Record Details
This FDA Inspection record concerns Sher Institute for Reproductive Medicine New Jersey P.A., with an inspection on March 14, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- March 14, 2011
- Product Type
- Biologics
View Company Profile
ID · 05499d66-49e3-4336-ba93-73344dcb2f8d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 713751
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
2- 21 CFR 1271.55(d)(1)Documentation maintained (general)
- 21 CFR 1271.47(a)Design of procedures to ensure compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sher Institute for Reproductive Medicine New Jersey P.A.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Sher Institute for Reproductive Medicine New Jersey P.A.
- FDA Inspection 616111 - 2009-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.